Videos
There are no videos available here.
00:02:00
The concept of The Hive is inspired from Eusociality, where members live, learn and work together, creating shared...
The concept of The Hive is inspired from Eusociality, where members live, learn and work together, creating shared value in the process. The Hive is the cent...
More
00:47:09
Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action...
Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review) - A TechNet Webinar with PATH - IDEA
More
00:48:58
On this episode of StarTalk Radio, Neil deGrasse Tyson sits down with first-time comic co-host Felicia Madison and...
On this episode of StarTalk Radio, Neil deGrasse Tyson sits down with first-time comic co-host Felicia Madison and returning friend of the show and Pulitzer ...
More
00:03:21
According to the life course approach to public health, your health today is the result of many different factors,...
According to the life course approach to public health, your health today is the result of many different factors, including your previous life experiences and even those of your parents. Likewise, your health today will impact your health in the future, as well as the health of the future generations.
More
00:18:48
Steve Davis is working to bring an extraordinary vision to reality—the global elimination of the world’s most deadly...
Steve Davis is working to bring an extraordinary vision to reality—the global elimination of the world’s most deadly and debilitating diseases. Davis is the president and CEO of PATH, a 40+ year-old, Seattle-based, global health-focused, non-governmental organization which works on vaccines, drugs, diagnostics, devices, and system and service innovations. In this talk, Davis lays out the “how to” of disease elimination calling on his diversity of experience as a former human-rights lawyer, a nationally-recognized technology business innovator, and social activist.
More
00:02:29
Launched at the 2016 World Economic Forum in Davos, INFUSE seeks tried and tested innovations that have potential to...
Launched at the 2016 World Economic Forum in Davos, INFUSE seeks tried and tested innovations that have potential to improve vaccine delivery. It then “infuses” them with capital and expertise to help take them to scale. INFUSE 2018 is calling for proven digital technology innovations that provide more effective methods of identity registration and authentication to accelerate and improve immunisation coverage and delivery.
More
00:02:01
Polio can’t be cured, but it can be prevented. Two important tools help to prevent polio – two safe, effective...
Polio can’t be cured, but it can be prevented. Two important tools help to prevent polio – two safe, effective vaccines. Find out about the oral polio vaccine and the inactivated poliovirus vaccine and their roles in the polio eradication effort.
More
00:06:34
In Spanish. The videos has messages from the leaders of polio eradication in the Americas.
00:41:26
Dr. Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention, discusses the achievements of the...
Dr. Thomas Frieden, Director, U.S. Centers for Disease Control and Prevention, discusses the achievements of the global polio programme and the way head, focussing on India's efforts.
More
00:03:08
On September 28, CSIS hosted a major international conference that brought together polio eradication leaders for a...
On September 28, CSIS hosted a major international conference that brought together polio eradication leaders for a full day of panels and discussion. Here is an interview with Michel Zaffra
More
00:03:15
MenAfriVac, a new vaccine against Meningococcal Meningitis seroptype Nm A, is expected to prevent meningitis...
MenAfriVac, a new vaccine against Meningococcal Meningitis seroptype Nm A, is expected to prevent meningitis epidemics in Africa's "meningitis belt" of 25 countries that stretch from Senegal in the west to Ethiopia in the east. Hit by epidemics every few years, the meningitis belt accounts for 95 percent of the world's meningococcal meningitis disease burden. The region's worst epidemic in recent times, the 1996 epidemic, hit more than 250,000 people in the region, killing 25,000 people and causing residual disability for 50,000 others. Besides the death and disability though, meningitis epidemics have a profound socio-political significance too. Epidemics frighten people away from work and cost large amounts of money to handle. Developed by the Meningitis Vaccine Project, a joint project of PATH and WHO, the vaccine was launched in Burkina Faso in November 2010. MenAfriVac costs less than 50 US cents per dose and is 95 percent effective. The GAVI Alliance is paying the overwhelming majority of costs to roll the vaccine out. If fully funded, GAVI expects to see 236 million people vaccinated with MenAfriVac in all 25 countries of the meningitis belt.
More
00:46:56
This documentary examines the remarkable global response to devastating meningitis A outbreaks in Africa and the...
This documentary examines the remarkable global response to devastating meningitis A outbreaks in Africa and the rapid development of an affordable vaccine to eliminate these recurring epidemics.
More
00:03:52
Clinical research funded by Gavi partners at Patan Hospital in Kathmandu is helping shape Nepal’s immunisation...
Clinical research funded by Gavi partners at Patan Hospital in Kathmandu is helping shape Nepal’s immunisation policy against its biggest child killer: pneumonia. This video shows how disease burden and impact studies at Patan have guided the national introduction of Haemophilus influenzae type b and pneumococcal vaccines, which protect children against the two main causes of pneumonia.
More
07:31:44
Internationally recognized experts give research updates on vaccine work for worldwide problems, such as HIV and...
Internationally recognized experts give research updates on vaccine work for worldwide problems, such as HIV and Ebola, as well as updates on vaccine efforts of particular relevance to Montana, such as in brucellosis. Research efforts led by the Bill and Melinda Gates Foundation and Merck & Co., Inc., are also summarized.
More
N/A
Live Q&A on vaccine-derived polio in Syria with Michel Zaffran, WHO
00:02:10
As the first developing country to introduce the pneumococcal vaccine in April 2009, Rwanda made a major milestone...
As the first developing country to introduce the pneumococcal vaccine in April 2009, Rwanda made a major milestone for disease prevention in the developing world.
More
00:03:46
Some children live in places that are harder to reach with polio vaccines than others. In every vulnerable country,...
Some children live in places that are harder to reach with polio vaccines than others. In every vulnerable country, the World Health Organization helps make sure that every child receives polio vaccines; even those who are on the move, living in conflict zones or in remote communities. Find out more at www.polioeradication.org.
More
00:02:39
Film acknowledging the contribution of the people working towards the eradication of polio.
Unable to load tooltip content.